經濟通串流版 ET Net IQ Streaming - 北海康成－Ｂ CANBRIDGE PHARMACEUTICALS INC.

公司資料 - 股權變動

日期	股東名稱	披露原因	買入／賣出涉及的股份數目	每股平均價	持有權益的股份數目	佔已發行股本(%)
19/12/2023	RA Capital Management, L.P.	1201(L)	-62,165,590(L)		0(L)	0.00
19/12/2023	Kolchinsky Anna Inge Leonore Haas	1201(L)	-62,165,590(L)		0(L)	0.00
15/12/2023	Athos Asia Event Driven Master Fund	1001(L)	+40,541,216(L)		41,891,816(L)	9.87
15/12/2023	Athos Capital Limited	1001(L)	+52,665,590(L)		56,021,590(L)	13.20
15/12/2023	Schulte-Hillen Friedrich Bela	1001(L)	+52,665,590(L)		56,021,590(L)	13.20
15/12/2023	Moskey Matthew Love	1001(L)	+52,665,590(L)		56,021,590(L)	13.20

1 2

備註：	(L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。
	(S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。
	(P) - 可供借出的股份

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.